HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 291/2/E388    most recent 00621.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Streeper, R. S. Articles by Farese, R. V. Search for Related Content PubMed PubMed Citation Articles by Streeper, R. S. Articles by Farese, R. V., Jr.

Effects of DGAT1 deficiency on energy and glucose metabolism are independent of adiponectin

¹Gladstone Institute of Cardiovascular Disease; ²Cardiovascular Research Institute and Departments of ³Medicine and ⁴Biochemistry and Biophysics, and ⁵The Diabetes Center, University of California, San Francisco, California

Submitted 7 December 2005 ; accepted in final form 20 March 2006

Mice lacking acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1), an enzyme that catalyzes the terminal step in triacylglycerol synthesis, have enhanced insulin sensitivity and are protected from obesity, a result of increased energy expenditure. In these mice, factors derived from white adipose tissue (WAT) contribute to the systemic changes in metabolism. One such factor, adiponectin, increases fatty acid oxidation and enhances insulin sensitivity. To test the hypothesis that adiponectin is required for the altered energy and glucose metabolism in DGAT1-deficient mice, we generated adiponectin-deficient mice and introduced adiponectin deficiency into DGAT1-deficient mice by genetic crosses. Although adiponectin-deficient mice fed a high-fat diet were heavier, exhibited worse glucose tolerance, and had more hepatic triacylglycerol accumulation than wild-type controls, mice lacking both DGAT1 and adiponectin, like DGAT1-deficient mice, were protected from diet-induced obesity, glucose intolerance, and hepatic steatosis. These findings indicate that adiponectin is required for normal energy, glucose, and lipid metabolism but that the metabolic changes induced by DGAT1-deficient WAT are independent of adiponectin and are likely due to other WAT-derived factors. Our findings also suggest that the pharmacological inhibition of DGAT1 may be useful for treating human obesity and insulin resistance associated with low circulating adiponectin levels.

triglyceride; adipose tissue; gene knockout; acyl-coenzyme A:diacylglycerol acyltransferase 1

This article has been cited by other articles:

				C.-L. E. Yen, S. J. Stone, S. Koliwad, C. Harris, and R. V. Farese Jr. Thematic Review Series: Glycerolipids. DGAT enzymes and triacylglycerol biosynthesis J. Lipid Res., November 1, 2008; 49(11): 2283 - 2301. [Abstract] [Full Text] [PDF]

				S. Otabe, X. Yuan, T. Fukutani, N. Wada, T. Hashinaga, H. Nakayama, N. Hirota, M. Kojima, and K. Yamada Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E210 - E218. [Abstract] [Full Text] [PDF]

				A. Turkish and S. L. Sturley Regulation of Triglyceride Metabolism. I. Eukaryotic neutral lipid synthesis: "Many ways to skin ACAT or a DGAT" Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G953 - G957. [Abstract] [Full Text] [PDF]